1995
DOI: 10.1128/mcb.15.6.3049
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin-2 Triggers a Novel Phosphatidylinositol 3-Kinase-Dependent MEK Activation Pathway

Abstract: , MEK, but did not inhibit activation of Raf, the canonical upstream activator of MEK. These results suggest that a novel wortmanninsensitive activation pathway regulates MEK and MAP kinase in IL-2-stimulated T lymphocytes.The interaction of a resting T cell with appropriately presented antigen initiates cell cycle entry (G 0 -to G 1 -phase transition) and the expression of high-affinity interleukin-2 (IL-2) receptors (IL-2R). The binding of IL-2 to the IL-2R then elicits G 1 -to S-phase progression and commit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
95
2
1

Year Published

1996
1996
2004
2004

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 142 publications
(106 citation statements)
references
References 69 publications
(78 reference statements)
8
95
2
1
Order By: Relevance
“…Host cell proliferation can be blocked by pharmacological inhibition of PI3-K In many different systems, PI3-K activity has been linked to proliferative pathways via activation of MAP kinase (Karnitz et al, 1995), p70S6K (Alessi et al, 1997), c-Jun N-terminal kinase (JNK) (Klippel et al, 1996), PKB or proteins of the PKC family (Akimoto et al, 1996;Sontag et al, 1997). To examine whether the continuous proliferation of T. parva-infected B cells depends on PI3-K activity, we took advantage of two unrelated PI3-K inhibitors, LY294002 and wortmannin.…”
Section: Resultsmentioning
confidence: 99%
“…Host cell proliferation can be blocked by pharmacological inhibition of PI3-K In many different systems, PI3-K activity has been linked to proliferative pathways via activation of MAP kinase (Karnitz et al, 1995), p70S6K (Alessi et al, 1997), c-Jun N-terminal kinase (JNK) (Klippel et al, 1996), PKB or proteins of the PKC family (Akimoto et al, 1996;Sontag et al, 1997). To examine whether the continuous proliferation of T. parva-infected B cells depends on PI3-K activity, we took advantage of two unrelated PI3-K inhibitors, LY294002 and wortmannin.…”
Section: Resultsmentioning
confidence: 99%
“…These results are consistent with a role for ATM in hypertonicity-induced activation of TonEBP͞ OREBP. However, because wortmannin also inhibits other phosphatidylinositol kinase kinases, including DNA-PK and phosphatidylinositol 3-kinase (23,24), additional experiments were required to confirm the role of ATM.…”
Section: Resultsmentioning
confidence: 99%
“…Activation of PKC contributes to Raf/Erk-1/2 activation in response to cyclic pressure-induced strain in endothelial cells (36). Ras-mediated activation of Erk-1/2, either by insulin, insulin like-growth factor I, interleukin-8 and -2, platelet-derived growth factor, vasopressin, T cell receptor, and adrenergic receptors is increased by Raf-1 co-activation by PI3-K (37)(38)(39)(40)(41)(42)(43). Although a direct effect of CaM on Raf-1 activity has been proposed in response to epidermal growth factor receptor activation, a direct CaMKII/Raf-1 interaction has not yet been described (21,22,44).…”
Section: Discussionmentioning
confidence: 99%